Lv11
40 积分 2025-08-07 加入
Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease
6小时前
待确认
GLP-1-based therapies for diabetes, obesity and beyond
3个月前
已完结
Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation
4个月前
已完结
皖公网安备34019202002308
